Erythropoietin: Endogenous Protection of Ischemic Brain

Vitamins and Hormones

Volumn 105, Issue , 2017, Pages 197-232

  Mallet, Robert T ^a   Ryou, Myoung Gwi ^a,b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b TARLETON STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Blood brain barrier; Cardiac arrest; Caspase; Glutamate; Inflammation; Matrix metalloproteinase; Reactive oxygen species; Stroke

Indexed keywords

ERYTHROPOIETIN; NEUROPROTECTIVE AGENT;

ANIMAL; BRAIN; BRAIN ISCHEMIA; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; ERYTHROPOIETIN; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REPERFUSION INJURY;

EID: 85014160309     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2017.01.002     Document Type: Chapter

References (177)

1. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., Begley, D.J., Structure and function of the blood-brain barrier. Neurobiology of Disease 37 (2010), 13–25.
2. Abramov, A.Y., Duchen, M.R., Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochimica et Biophysica Acta 1777 (2008), 953–964.
3. Adibhatla, R.M., Hatcher, J.F., Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: Therapeutic strategies. CNS and Neurological Disorders Drug Targets 7 (2008), 243–253.
4. Albers, G.W., Goldstein, L.B., Hall, D., Lesko, L.M., Aptiganel acute stroke investigators, Aptigel hydrochloride in acute stroke: A randomized controlled trial. JAMA 286 (2001), 2673–2682.
5. Allan, L.A., Morrice, N., Brady, S., Magee, G., Pathak, S., Clarke, P.R., Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nature Cell Biology 5 (2003), 647–654.
6. Amé, J.C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., et al. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. The Journal of Biological Chemistry 274 (1999), 17860–17868.
7. Andoh, T., Echigo, N., Kamiya, Y., Hayashi, M., Kudoh, I., Goto, T., Effects of erythropoietin on intracellular calcium concentration of rat primary cortical neurons. Brain Research 1387 (2011), 8–18.
8. Asadi, B., Askari, G.R., Khorvash, F., Bagherpur, A., Mehrabi, F., Karimi, M., et al. Neuroprotective effects of erythropoietin in acute ischemic stroke. International Journal of Preventive Medicine 4:Suppl. 2 (2013), S306–S312.
9. Bahcekapili, N., Uzüm, G., Gökkusu, C., Kuru, A., Ziylan, Y.Z., The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats. Life Sciences 80 (2007), 1245–1251.
10. Baines, C.P., The cardiac mitochondrion: Nexus of stress. Annual Review of Physiology 72 (2010), 61–80.
11. Beckman, J.S., Koppenol, W.H., Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. American Journal of Physiology. Cell Physiology 271 (1996), C1424–C1437.
12. Begley, D.J., Brightman, D.W., Structural and functional aspects of the blood-brain barrier. Progress in Drug Research 61 (2003), 39–78.
13. Bernard, S.A., Gray, T.W., Buist, M.D., Jones, B.M., Silvester, W., Gutteridge, G., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. The New England Journal of Medicine 346 (2002), 557–563.
14. Bernaudin, M., Nedelec, A.S., Divoux, D., MacKenzie, E.T., Petit, E., Schumann-Bard, P., Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. Journal of Cerebral Blood Flow and Metabolism 22 (2002), 393–403.
15. Brines, M., What evidence supports use of erythropoietin as a novel neurotherapeutic?. Oncology 16 (2002), 79–89.
16. Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences of the United States of America 97 (2000), 10526–10531.
17. Broughton, B.R., Reutens, D.C., Sobey, C.G., Apoptotic mechanisms after cerebral ischemia. Stroke 40 (2009), e331–e339.
18. Brouns, R., De Deyn, P.P., The complexity of neurobiological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery 111 (2009), 483–495.
19. Brown, G.C., Borutaite, V., Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochimica et Biophysica Acta 1658 (2004), 44–49.
20. Buemi, M., Allegra, A., Corica, F., Floccari, F., D'Avella, D., Aloisi, C., et al. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrology, Dialysis, Transplantation 15 (2000), 422–423.
21. Burtscher, M., Pachinger, O., Ehrenbourg, I., Mitterbauer, G., Faulhaber, M., Pühringer, R., et al. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. International Journal of Cardiology 96 (2004), 247–254.
22. Byts, N., Samoylenko, A., Fasshauer, T., Ivanisevic, M., Hennighausen, L., Ehrenreich, H., et al. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death and Differentiation 15 (2008), 783–792.
23. Calapai, G., Marciano, M.C., Corica, F., Allegra, A., Parisi, A., Frisina, N., et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. European Journal of Pharmacology 401 (2000), 349–356.
24. Candelario-Jalil, E., Injury and repair mechanisms in ischemic stroke: Considerations for the development of novel neurotherapeutics. Current Opinion in Investigational Drugs 10 (2009), 644–654.
25. Carelli, S., Ghilardi, G., Bianciardi, P., Latorre, E., Rubino, F., Bissi, M., et al. Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping. Neurological Sciences 37 (2016), 243–252.
26. Chang, J.J., Emanuel, B.A., Mack, W.J., Tsivgoulis, G., Alexandrov, A.V., Matrix metalloproteinase-9: Dual role and temporal profile in intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases 23 (2014), 2498–2505.
27. Chaturvedi, M., Kaczmarek, L., Mmp-9 inhibition: A therapeutic strategy in ischemic stroke. Molecular Neurobiology 49 (2014), 563–573.
28. Chen, Z.Y., Wang, L., Asavaritkrai, P., Noguchi, C.T., Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. Journal of Neuroscience Research 88 (2010), 3180–3188.
29. Chong, Z.Z., Li, F., Maiese, K., Stress in the brain: Novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Research. Brain Research Reviews 49 (2005), 1–21.
30. Clark, D.D., Sokoloff, L., Circulation and energy metabolism of the brain. Siegel, G.J., Agranoff, B.W., Albers, R.W., Fisher, S.K., Uhler, M.D., (eds.) Basic neurochemistry: Molecular, cellular and medical aspects, 1999, Lippincott, Philadelphia, 637–670.
31. Costa, D.C., Alva, N., Trigueros, L., Gamez, A., Carbonell, T., Rama, R., Intermittent hypobaric hypoxia induces neuroprotection in kainate-induced oxidative stress in rats. Journal of Molecular Neuroscience 50 (2013), 402–410.
32. Dallas, M., Boycott, H.E., Atkinson, L., Miller, A., Boyle, J.P., Pearson, H.A., et al. Hypoxia suppresses glutamate transport in astrocytes. The Journal of Neuroscience 27 (2007), 3946–3955.
33. Dame, C., Juul, S.E., Christensen, R.D., The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate 79 (2001), 228–235.
34. Dang, S., Liu, X., Fu, P., Gong, W., Yan, F., Han, P., et al. Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats. Neurological Research 33 (2011), 520–528.
35. Davis, S.M., Lees, K.R., Albers, G.W., Diener, H.C., Markabi, S., Karlsson, G., et al. Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist. Stroke 31 (2000), 347–354.
36. Dejonckheere, E., Vandenbroucke, R.E., Libert, C., Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. Drug Discovery Today 16 (2011), 762–778.
37. Derex, L., Nighoghossian, N., Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: An update. Journal of Neurology, Neurosurgery, and Psychiatry 79 (2008), 1093–1099.
38. Digicaylioglu, M., Lipton, S.A., Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001), 641–647.
39. Doeppner, T.R., Hermann, D.M., Free radical scavengers and spin traps—Therapeutic implications for ischemic stroke. Best Practice & Research. Clinical Anaesthesiology 24 (2010), 511–520.
40. Eaton, P., Wright, N., Hearse, D.J., Shattock, M.J., Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. Journal of Molecular and Cellular Cardiology 34 (2002), 1549–1560.
41. Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Molecular Medicine 8 (2002), 495–505.
42. Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40 (2009), e647–e656.
43. Elting, J.W., Sulter, G.A., Kaste, M., Lees, K.R., Diener, H.C., Hommel, M., et al. AMPA antagonist ZK200775 in patients with acute ischemic stroke: Possible glial cell toxicity detected by monitoring of S-100B serum levels. Stroke 33 (2002), 2813–2818.
44. Fan, X., Heijnen, C.J., van der Kooij, M.A., Groenendaal, F., van Bel, F., The role and regulation of hypoxia-inducible factor-1a expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Research Reviews 62 (2009), 99–108.
45. Fandrey, J., Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 286 (2004), R977–R988.
46. Ferdinandy, P., Schulz, R., Nitric oxide, superoxide and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning. British Journal of Pharmacology 138 (2003), 532–543.
47. Ferrer, I., Planas, A.M., Signaling of cell death and cell survival following focal cerebral ischemia: Life and death struggle in the penumbra. Journal of Neuropathology and Experimental Neurology 62 (2003), 329–339.
48. Fraser, P.A., The role of free radical generation in increasing cerebrovascular permeability. Free Radical Biology and Medicine 51 (2011), 967–977.
49. Genc, S., Akhisaroglu, M., Kuralay, F., Genc, K., Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neuroscience Letters 321 (2002), 73–76.
50. Ghosh, M., Yang, Y., Rothstein, J.D., Robinson, M.B., Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes. The Journal of Neuroscience 31 (2011), 9159–9169.
51. Girotra, S., Chan, P.S., Bradley, S.M., Post-resuscitation care following out-of-hospital and in-hospital cardiac arrest. Heart 101 (2015), 1943–1949.
52. Go, A.S., Mozaffarian, D., Roger, V.L., American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics—2013 update. Circulation 127 (2013), e6–e245.
53. Gonzalez, F.F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z., et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Developmental Neuroscience 29 (2007), 321–330.
54. Grasso, G., Sfacteria, A., Meli, F., Fodale, V., Buemi, M., Iacopino, D.G., Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Research 1182 (2007), 99–105.
55. Green, A.R., Pharmacological approaches to acute ischaemic stroke: Reperfusion certainly, neuroprotection possibly. British Journal of Pharmacology 153:Suppl. 1 (2008), S325–S338.
56. Grmec, Š., Strnad, M., Kupnik, D., Sinkovič, A., Gazmuri, R.J., Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 80 (2009), 631–637.
57. Gu, Y., Dee, C.M., Shen, J., Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Frontiers in Bioscience 3 (2011), 1216–1231.
58. Gu, G.J., Li, Y.P., Peng, Z.Y., Xu, J.J., Kang, Z.M., Xu, W.G., et al. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. Journal of Applied Physiology 104 (2008), 1185–1191.
59. Gunnarson, E., Song, Y., Kowalewski, J.M., Brismar, H., Brines, M., Cerami, A., et al. Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proceedings of the National Academy of Sciences of the United States of America 106 (2009), 1602–1607.
60. Haider, T., Casucci, G., Linser, T., Faulhaber, M., Gatterer, H., Ott, G., et al. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. Journal of Hypertension 27 (2009), 1648–1654.
61. Harada, H., Quearry, B., Ruiz-Vela, A., Korsmeyer, S.J., Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 15313–15317.
62. Hausladen, A., Fridovich, I., Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. The Journal of Biological Chemistry 269 (1994), 29405–29408.
63. Hazell, A.S., Excitotoxic mechanisms in stroke: An update of concepts and treatment strategies. Neurochemistry International 50 (2007), 941–953.
64. Hellewell, S.C., Yan, E.B., Alwis, D.S., Bye, N., Morganti-Kossmann, M.C., Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. Journal of Neuroinflammation, 10, 2013, 156.
65. Hypothermia after Cardiac Arrest Study Group, Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. The New England Journal of Medicine 346 (2002), 549–556.
66. Idris, A.H., Roberts, L.J. II, Caruso, L., Showstark, M., Layon, A.J., Becker, L.B., et al. Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation, and reperfusion. Critical Care Medicine 33 (2005), 2043–2048.
67. Ischiropoulos, H., Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Archives of Biochemistry and Biophysics 356 (1998), 1–11.
68. Jia, Y., Mo, S.J., Feng, Q.Q., Zhan, M.L., OuYang, L.S., Chen, J.C., et al. EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease. Journal of Molecular Neuroscience 53 (2014), 117–124.
69. Jickling, G.C., Liu, D., Stamova, B., Ander, B.P., Zhan, X., Lu, A., et al. Hemorrhagic transformation after ischemic stroke in animals and humans. Journal of Cerebral Blood Flow and Metabolism 34 (2014), 185–199.
70. Jin, K., Mao, X.O., Zhu, Y., Greenberg, D.A., MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. Journal of Neurochemistry 80 (2002), 119–125.
71. Jin, R., Yang, G., Li, G., Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: Critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiology of Disease 38 (2010), 376–385.
72. Jones, S.M., Novak, A.E., Elliott, J.P., The role of HIF in cobalt-induced ischemic tolerance. Neuroscience 252 (2013), 420–430.
73. Juul, S.E., McPherson, R.J., Farrell, F.X., Jolliffe, L., Ness, D.J., Gleason, C.A., Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biology of the Neonate 85 (2004), 138–144.
74. Kalaria, R.N., The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging 21 (2000), 321–330.
75. Kalogeris, T., Bao, Y., Korthuis, R.J., Mitochondrial reactive oxygen species: A double edged sword in ischemia/reperfusion vs preconditioning. Redox Biology 2 (2014), 702–714.
76. Kato, H., Kogure, K., Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cellular and Molecular Neurobiology 19 (1999), 93–108.
77. Kawakami, M., Sekiguchi, M., Sato, K., Kozaki, S., Takahashi, M., Erythropoietin receptor-mediated inhibition of exocytoxic glutamate release confers neuroprotection during chemical ischemia. The Journal of Biological Chemistry 276 (2001), 39469–39475.
78. Kilic, U., Kilic, E., Soliz, J., Bassetti, C.I., Gassmann, M., Hermann, D.M., Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. The FASEB Journal 19 (2005), 249–251.
79. Kim, K., Lee, S.G., Kegelman, T.P., Su, Z.Z., Das, S.K., Dash, R., et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. Journal of Cellular Physiology 226 (2011), 2484–2493.
80. Kim, M.S., Seo, Y.K., Park, H.J., Lee, K.H., Lee, K.H., Choi, E.J., et al. The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats. Korean Journal of Pediatrics 53 (2010), 898–908.
81. Kimura, C., Oike, M., Ito, Y., Hypoxia-induced alterations in Ca2 + mobilization in brain microvascular endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000), H2310–H2318.
82. Kimura, T., Sako, K., Tanaka, K., Kusakabe, M., Tanaka, T., Nakada, T., Effect of mild hypothermia on energy state recovery following transient forebrain ischemia in the gerbil. Experimental Brain Research 145 (2002), 83–90.
83. Kogure, T., Kogure, K., Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention). Clinical Neuroscience 4 (1997), 179–183.
84. Konstady, B.B., The role of glutamate in neuronal ischemic injury: The role of spark in fire. Neurological Sciences 33 (2012), 223–237.
85. Lakic, N., Surlan, K., Jerin, A., Meglic, B., Curk, N., Bunc, M., Importance of erythropoietin in brain protection after cardiac surgery: A pilot study. The Heart Surgery Forum 13 (2010), E185–E189.
86. Lan, K.M., Tien, L.T., Cai, Z., Lin, S., Pang, Y., Tanaka, S., et al. Erythropoietin ameliorates neonatal hypoxia-ischemia-induced neurobehavioral deficits, neuroinflammation, and hippocampal injury in the juvenile rat. International Journal of Molecular Sciences, 17, 2016, E289.
87. Lankhorst, C.E., Wish, J.B., Anemia in renal disease: Diagnosis and management. Blood Reviews 24 (2010), 39–47.
88. Larpthaveesarp, A., Georgevits, M., Ferriero, D.M., Gonzalez, F.F., Delayed erythropoietin therapy improves histological and behavioral outcomes after transient neonatal stroke. Neurobiology of Disease 93 (2016), 57–63.
89. Laver, S., Farrow, C., Turner, D., Nolan, J., Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Medicine 30 (2004), 2126–2128.
90. Li, Y., Lu, Z., Keogh, C.L., Yu, S.P., Wei, L., Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. Journal of Cerebral Blood Flow and Metabolism 27 (2007), 1043–1054.
91. Li, G., Ma, R., Huang, C., Tang, Q., Fu, Q., Liu, H., et al. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neuroscience Letters 442 (2008), 143–147.
92. Liao, Z.B., Jiang, G.Y., Tang, Z.H., Zhi, X.G., Sun, X.C., Tang, W.Y., et al. Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats. Neurology India 57 (2009), 722–728.
93. Liao, Z.B., Zhi, X.G., Shi, Q.H., He, Z.H., Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. European Journal of Neurology 15 (2008), 140–149.
94. Liu, R., Suzuki, A., Guo, Z., Mizuno, Y., Urabe, T., Intrinsic and extrinsic erythropoietin enhances neuroprtection against ischemia and reperfusion injury in vitro. Journal of Neurochemistry 96 (2006), 1101–1110.
95. Loor, G., Schumacker, P.T., Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death and Differentiation 15 (2008), 686–690.
96. Lourhmati, A., Buniatian, G.H., Paul, C., Verleysdonk, S., Buecheler, R., Buadze, M., et al. Age-dependent astroglial vulnerability to hypoxia and glutamate: The role for erythropoietin. PloS One, 8, 2013, e77182.
97. Lund, A., Lundby, C., Olsen, N.V., High-dose erythropoietin for tissue protection. European Journal of Clinical Investigation 44 (2014), 1230–1238.
98. Ma, R., Hu, J., Huang, C., Wang, M., Xiang, J., Li, G., JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35. British Journal of Pharmacology 171 (2014), 3234–3245.
99. Madl, C., Holzer, M., Brain function after resuscitation from cardiac arrest. Current Opinion in Critical Care 10 (2004), 213–217.
100. Maiese, K., The dynamics of cellular injury: Transformation into neuronal and vascular protection. Histology and Histopathology 16 (2001), 633–644.
101. Maiese, K., Li, F., Chong, Z.Z., Erythropoietin in the brain: Can the promise to protect be fulfilled?. Trends in Pharmacological Sciences 25 (2004), 577–583.
102. Malhotra, S., Savitz, S.I., Ocava, L., Rosenbaum, D.M., Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. Journal of Neuroscience Research 83 (2006), 19–27.
103. Manukhina, E.B., Downey, H.F., Mallet, R.T., Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Experimental Biology and Medicine 231 (2006), 343–365.
104. Marti, H.H., Erythropoietin and the hypoxic brain. The Journal of Experimental Biology 207 (2004), 3233–3242.
105. Marti, H.H., Gassmann, M., Wenger, R.H., Kvietikova, I., Morganti-Kossmann, M.C., Kossmann, T., et al. Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain. Kidney International 51 (1997), 416–418.
106. Martin, L.J., Al-Abdulla, N.A., Brambrink, A.M., Kirsch, J.R., Sieber, F.E., Portera-Cailliau, C., Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Research Bulletin 46 (1998), 281–309.
107. Maznyczka, A.M., Gershlick, A.H., Therapeutic hypothermia in patients with out-of-hospital arrest. Heart 101 (2015), 1265–1271.
108. McPherson, R.J., Juul, S.E., Recent trends in erythropoietin-mediated neuroprotection. International Journal of Developmental Neuroscience 26 (2008), 103–111.
109. Merelli, A., Czornyj, L., Lazarowski, A., Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. The International Journal of Neuroscience 125 (2015), 793–797.
110. Mozaffarian, D., Benjamin, E.J., Go, A.S., American Heart Association Statistics Committee, Stroke Statistics Committee, Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation 133 (2016), e38–e360.
111. Nguyen, A.Q., Cherry, B.H., Scott, G.F., Ryou, M.G., Mallet, R.T., Erythropoietin: Powerful protection of ischemic and post-ischemic brain. Experimental Biology and Medicine 239 (2014), 1461–1475.
112. Nolan, J.P., Neumar, R.W., Adrie, C., Aibiki, M., Berg, R.A., Böttiger, B.W., et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79 (2008), 350–379.
113. Ogle, M.E., Gu, X., Espinera, A.R., Wei, L., Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1a. Neurobiology of Disease 45 (2012), 733–742.
114. Olivencia-Yurvati, A.H., Mallet, R.T., Inflammatory response and miniaturized cardiopulmonary bypass. Gourlay, T., Gunaydin, S., (eds.) Minimized cardiopulmonary bypass techniques and technologies, 2012, Woodhead Publishing Ltd., Cambridge, 86–112.
115. Olmez, I., Ozyurt, H., Reactive oxygen species and ischemic cerebrovascular disease. Neurochemistry International 60 (2012), 208–212.
116. Ovbiagele, B., Kidwell, C.S., Starkman, S., Saver, J.L., Neuroprotective agents for the treatment of acute ischemic stroke. Current Neurology and Neuroscience Reports 3 (2003), 9–20.
117. Paciaroni, M., Caso, V., Agnelli, G., The concept of ischemic penumbra in acute stroke and therapeutic opportunities. European Neurology 61 (2009), 321–330.
118. Prentice, H., Modi, J.P., Wu, J.Y., Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxidative Medicine and Cellular Longevity, 2015, 2015, 964518.
119. Pugh, C.W., Modulation of the hypoxic response. Advances in Experimental Medicine and Biology 903 (2016), 259–271.
120. Rabie, T., Marti, H.H., Brain protection by erythropoietin: A manifold task. Physiology 23 (2008), 263–274.
121. Rami, A., Bechmann, I., Stehle, J.H., Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Progress in Neurobiology 85 (2008), 273–296.
122. Ramos-Fernandez, M., Bellolio, M.F., Stead, L.G., Matrix metalloproteinase-9 as a marker for acute ischemic stroke: A systematic review. Journal of Stroke and Cerebrovascular Diseases 20 (2011), 47–54.
123. Rangarajan, V., Juul, S.E., Erythropoietin: Emerging role of erythropoietin in neonatal neuroprotection. Pediatric Neurology 51 (2014), 481–488.
124. Ratilal, B.O., Arroja, M.M., Rocha, J.P., Fernandes, A.M., Barateiro, A.P., Brites, D.M., et al. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion. Journal of Neurosurgery 121 (2014), 55–62.
125. Reddy, S., Jones, A.D., Cross, C.E., Wong, P.S., Van Der Vliet, A., Inactivation of creatine kinase by S-glutathionylation of the active-site cysteinyl residue. The Biochemical Journal 347 (2000), 821–827.
126. Reischl, S., Li, L., Walkinshaw, G., Flippin, L.A., Marti, H.H., Kunze, R., Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke. PloS One, 9, 2014, e84767.
127. Renzi, M.J., Farrell, F.X., Bittner, A., Galindo, J.E., Morton, M., Trinh, H., et al. Erythropoietin induces changes in gene expression in PC-12 cells. Brain Research. Molecular Brain Research 104 (2002), 86–95.
128. Robertson, C.L., Scafidi, S., McKenna, M.C., Fiskum, G., Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Experimental Neurology 218 (2009), 371–380.
129. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., American Heart Association Statistics Committee, Stroke Statistics Committee, Heart disease and stroke statistics–2012 update. Circulation 125 (2012), e2–e220.
130. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996), 675–686.
131. Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. The Journal of Neuroscience 22 (2002), 10291–10301.
132. Ryou, M.G., Choudhury, G.R., Li, W., Winters, A., Yuan, F., Liu, R., et al. Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress. Neuroscience 301 (2015), 193–203.
133. Ryou, M.G., Liu, R., Ren, M., Sun, J., Mallet, R.T., Yang, S.-H., Pyruvate protects brain against ischemia-reperfusion injury by activating erythropoietin signaling. Stroke 43 (2012), 1101–1107.
134. Sakanaka, M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proceedings of the National Academy of Sciences of the United States of America 95 (1998), 4635–4640.
135. Schouten, J.W., Neuroprotection in traumatic brain injury: A complex struggle against the biology of nature. Current Opinion in Critical Care 13 (2007), 134–142.
136. Selivanov, V.A., Votyakova, T.V., Pivtoraiko, V.N., Zeak, J., Sukhomlin, T., Trucco, M., et al. Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Computational Biology, 7, 2011, e1001115.
137. Sen, T., Sen, N., Treatment with an activator of hypoxia-inducible factor 1, DMOG provides neuroprotection after traumatic brain injury. Neuropharmacology 107 (2016), 79–88.
138. Shang, Y., Wu, Y., Yao, S., Wang, X., Feng, D., Yang, W., Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: Involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis 12 (2007), 2187–2195.
139. Shein, N.A., Tsenter, J., Alexandrovich, A.G., Horowitz, M., Shohami, E., Akt phosphorylation is required for heat acclimation-induced neuroprotection. Journal of Neurochemistry 103 (2007), 1523–1529.
140. Shuaib, A., Lees, K.R., Lyden, P., Grotta, J., Davalos, A., Davis, S.M., et al. NXY-059 for the treatment of acute ischemic stroke. The New England Journal of Medicine 357 (2007), 562–571.
141. Siddiq, A., Aminova, L.R., Ratan, R.R., Hypoxia inducible factor prolyl 4-hydroxylase enzymes: Center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochemical Research 32 (2007), 931–946.
142. Sims, B., Clarke, M., Njah, W., Hopkins, E.S., Sontheimer, H., Erythropoietin-induced neuroprotection requires cysteine glutamate exchanger activity. Brain Research 1321 (2010), 88–95.
143. Sims, N.R., Muyderman, H., Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta 1802 (2010), 80–91.
144. Sirén, A.L., Ehrenreich, H., Erythropoietin—A novel concept for neuroprotection. European Archives of Psychiatry and Clinical Neuroscience 251 (2001), 179–184.
145. Sola, A., Rogido, M., Lee, B.H., Genetta, T., Wen, T.C., Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatric Research 57 (2005), 481–487.
146. Song, J., Sun, H., Xu, F., Kang, W., Gao, L., Guo, J., et al. Recombinant human erythropoietin improves neurological outcomes in very preterm infants. Annals of Neurology 80 (2016), 24–34.
147. Souvenir, R., Fathali, N., Ostrowski, R.P., Lekic, T., Zhang, J.H., Tang, J., Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiology of Disease 44 (2011), 28–37.
148. Suzuki, Y., Nagai, N., Umemura, K., A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Frontiers in Cellular Neuroscience, 10, 2016, 2.
149. Svedin, P., Hagberg, H., Sävman, K., Zhu, C., Mallard, C., Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. The Journal of Neuroscience 27 (2007), 1511–1518.
150. Swanson, R.A., Ying, W., Kauppinen, T.M., Astrocyte influences on ischemic neuronal death. Current Molecular Medicine 4 (2004), 193–205.
151. Trollmann, R., Richter, M., Jung, S., Walkinshaw, G., Brackmann, F., Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death. Neuroscience 278 (2014), 327–342.
152. Turner, R.C., Dodson, S.C., Rosen, C.L., Huber, J.D., The science of cerebral ischemia and the quest for neuroprotection: Navigating past failure to future success. Journal of Neurosurgery 118 (2013), 1072–1085.
153. Turner, R.J., Sharp, F.R., Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Frontiers in Cellular Neuroscience 10 (2016), 1–13.
154. Vafadari, B., Salamian, A., Kaczmarek, L., MMP-9 in translation: From molecule to brain physiology, pathology and therapy. Journal of Neurochemistry 139:Suppl. 2 (2016), 91–114.
155. Vairano, M., Dello Russo, C., Pozzoli, G., Battaglia, A., Scambia, G., Tringali, G., et al. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. The European Journal of Neuroscience 16 (2002), 584–592.
156. Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. The Journal of Experimental Medicine 198 (2003), 971–975.
157. Wang, R., Wu, X., Liang, J., Qi, Z., Liu, X., Min, L., et al. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion. The International Journal of Neuroscience 125 (2015), 693–702.
158. Wen, T.C., Sadamoto, Y., Tanaka, J., Zhu, P.X., Nakata, K., Ma, Y.J., et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. Journal of Neuroscience Research 67 (2002), 795–803.
159. Wenger, R.H., Hoogewijs, D., Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. American Journal of Physiology. Renal Physiology 298 (2010), F1287–F1296.
160. Westfal, R.E., Reissman, S., Doering, G., Out-of-hospital cardiac arrests: An 8-year New York City experience. The American Journal of Emergency Medicine 14 (1996), 364–368.
161. White, B.C., Sullivan, J.M., DeGracia, D.J., O'Neil, B.J., Neumar, R.W., Grossman, L.I., et al. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. Journal of the Neurological Sciences 179 (2000), 1–33.
162. Wu, Y.W., Mathur, A.M., Chang, T., McKinstry, R.C., Mulkey, S.B., Mayock, D.E., et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: A phase II trial. Pediatrics, 137, 2016, e20160191.
163. Xiong, Y., Chopp, M., Lee, C.P., Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury. Neurological Research 31 (2009), 496–502.
164. Xiong, Y., Lu, D., Qu, C., Goussev, A., Schallert, T., Mahmood, A., et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. Journal of Neurosurgery 109 (2008), 510–521.
165. Xu, X., Dai, H., Shi, Y., Erythropoietin protects primary cultures of rat cortical neurons from hypoxia-induced toxicity through attenuating both glutamate release and NMDA receptor evoked neurotoxicity pathway. Pharmazie 64 (2009), 210–213.
166. Yang, Y., Rosenberg, G.A., Matrix metalloproteinases as therapeutic targets for stroke. Brain Research 1623 (2015), 30–38.
167. Yu, T., Longhini, F., Wu, R., Yao, W., Lu, W., Jin, X., The role of the induction of mild hypothermia in adult patient outcomes after cardiac arrest: Systematic review and meta-analysis of randomized controlled studies. The Journal of International Medical Research 43 (2015), 471–482.
168. Zhang, F., Signore, A.P., Zhou, Z., Wang, S., Cao, G., Chen, J., Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: Potential signaling mechanisms. Journal of Neuroscience Research 83 (2006), 1241–1251.
169. Zhang, F., Wang, S., Cao, G., Gao, Y., Chen, J., Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia. Neurobiology of Disease 25 (2007), 45–53.
170. Zhang, J., Wang, Q., Xiang, H., Xin, Y., Chang, M., Lu, H., Neuroprotection with erythropoietin in preterm and/or low birth weight infants. Journal of Clinical Neuroscience 21 (2014), 1283–1287.
171. Zhang, X.W., Xie, J.F., Chen, J.X., Huang, Y.Z., Guo, F.M., Yang, Y., et al. The effect of mild induced hypothermia on outcomes of patients after cardiac arrest: A systematic review and meta-analysis of randomised controlled trials. Critical Care, 19, 2015, 417.
172. Zhang, F., Xing, J., Liou, A.K., Wang, S., Gan, Y., Luo, Y., et al. Enhanced delivery of erythropoietin across the blood-brain barrier for neuroprotection against ischemic neuronal injury. Translational Stroke Research 1 (2010), 113–121.
173. Zhang, Y., Xiong, Y., Mahmood, A., Meng, Y., Qu, C., Schallert, T., et al. Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit. Brain Research 1294 (2009), 153–164.
174. Zhao, H., Wang, R., Wu, X., Liang, J., Qi, Z., Liu, X., et al. Erythropoietin delivered via intra-arterial infusion reduces endoplasmic reticulum stress in brain microvessels of rats following cerebral ischemia and reperfusion. Journal of Neuroimmune Pharmacology 10 (2015), 153–161.
175. Zheng, Z., Zhao, H., Steinberg, G.K., Yenari, M.A., Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News & Perspectives 16 (2003), 497–503.
176. Zhou, T.F., Yu, J.G., Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia. The Journal of Surgical Research 183 (2013), 304–312.
177. Zhou, J., Yu, J.T., Wang, H.F., Meng, X.F., Tan, C.C., Wang, J., et al. Association between stroke and Alzheimer's disease: Systematic review and meta-analysis. Journal of Alzheimer's Disease 43 (2015), 479–489.